Human T-lymphoblastic Leukemia (TLL) Homo sapiens (Human) Cell

T-lymphoblastic leukemia/lymphoma; J.gamma1.WT; Jurkat; A3; HuT 78; 6T-CEM; P116

  • UOM
    1. 5X10^5
  • FOB US$ 400.00
  • Quantity
Add to Cart Distributors
Overview
Properties
  • StrainHuman, male
  • Tissue SourceJurkat Clone E6-1 ( cell line from peripheral blood
  • Growth PropertiesSuspension
  • Cell TypeT lymphocyte
  • DiseaseAcute T cell leukemia
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Human T-lymphoblastic Leukemia (TLL) Packages (Simulation)
  • Human T-lymphoblastic Leukemia (TLL) Packages (Simulation)
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Biosafety

Human T-lymphoblastic Leukemia (TLL) are negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast and fungi.

Cluture conditions

RPMI-1640+10%FBS+1%Penicillin-Streptomycin Solution. Temperature: 37℃

Product format

Frozen 1 mL or T25 flask.

Usage

Upon receiving the cells in a T-25 flask at room temperature, immediately transfer the cells to 37°C, 5% incubator; the cells in vials, directly and immediately transfer the cells from dry ice to liquid nitrogen.

Giveaways

Recommend products